You are currently visiting Medline.com in a browser which is not supported. This may reduce the functionality of the website. For the best experience, please upgrade your browser, or switch to a supported browser. For a list of supported browsers visit: https://www.medline.com/help/tech-support/

Multicenter Randomized Clinical Study of Accuryn vs. Criticore

Multicenter Randomized Clinical Study of Accuryn vs. Criticore 2018-06-05T15:23:48+00:00

Multicenter Randomized Clinical Study of Accuryn vs. Criticore.

Accuryn was shown to be significantly superior to BARD CRITICORE in the burn unit setting with hourly urine output monitoring in multicenter randomized controlled study (RCT-ClinicalTrials.gov Identifier: NCT02195713).

The chart below shows a characteristic comparison of urine output over time in a patient using the standard of care device and one using Accuryn.

The impact of airlock reduction on effective continuous urine output was pronounced and found to be statistically significant over the entire study population for:

  • No airlocks (p<0.001)
  • No periods of false oliguria (p<0.05) in test patients
  • No periods of false anuria (p<0.05) in test patients